Compare StocksABT vs TMO

Abbott Laboratories (ABT) vs Thermo Fisher Scientific Inc. (TMO): Which Is the Better Buy in 2026?

As of 2026-06-19, ABT is fairly valued at $88, with a DCF intrinsic value of $93 and a margin of safety of 5%. TMO is overvalued at $465, with an intrinsic value of $407 and a margin of safety of -14%. Of the two, ABT has the wider margin of safety.

ABT
Abbott Laboratories
$88.41
VS
TMO
Thermo Fisher Scientific Inc.
$464.61

Rewards

ABT
  • Abbott Laboratories scores 86/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Insiders have bought $1.1M worth of stock in the past 3 months — significant skin in the game.
  • Altman Z-Score of 5.60 indicates very low bankruptcy risk — the company is firmly in the safe zone.
TMO
  • Trailing P/E of 25.5x is 21% below the historical average of 32.3x — potentially undervalued relative to its own history.
  • Altman Z-Score of 3.85 indicates very low bankruptcy risk — the company is firmly in the safe zone.

Risks

ABT
    TMO
    • 21 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

    Key Valuation Metrics

    Learn more →
    ABT
    TMO
    Valuation
    $6.34B
    Free Cash Flow
    $5.52B
    4.12%
    FCF Yield
    3.20%
    24.76
    Trailing P/E
    25.53
    14.59
    Forward P/E
    17.05
    Quality & Moat
    5.53%
    ROIC
    6.71%
    12.33%
    ROE
    13.52%
    56.50%
    Gross Margin
    40.93%
    1.34
    PEG Ratio
    1.55
    Balance Sheet Safety
    0.51
    Net Debt / Equity
    0.77
    N/A
    Interest Coverage
    N/A
    2.29
    Net Debt / EBITDA
    3.53
    2.76%
    Dividend Yield
    0.40%
    ABT: 8Ties: 2TMO: 2
    ABTTMO

    Historical Fundamentals

    Learn more →
    ABT

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    TMO

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    ABT
    $1.89
    created per $1 retained over 3 years
    Value Creator
    Σ Retained
    $14.14B
    Δ Market Cap
    +$26.79B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    TMO
    $0.17
    created per $1 retained over 3 years
    Value Destroyer
    Σ Retained
    $17.29B
    Δ Market Cap
    +$2.95B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    ABT
    4.8% Margin of Safety
    Price is 4.8% below estimated fair value
    Current Price: $88.41
    Fair Value: $92.91
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    TMO
    14.3% Overvalued
    Price is 14.3% above estimated fair value
    Current Price: $464.61
    Fair Value: $406.54
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    ABT

    What growth rate is the market pricing in at $88?

    +10.3%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +12.5%

    The market implies +10.3% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +12.5%, reflecting heavy growth investment.

    TMO

    What growth rate is the market pricing in at $465?

    +11.6%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +16.6%

    The market implies +11.6% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +16.6%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    ABT
    86/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Margin Stability is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    TMO
    60/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with margin stability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    ABT
    -2.48
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    TMO
    -2.47
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    ABT
    Insiders 0.5%Institutions 82.7%Retail & Other 16.8%
    No. of Institutional Holders3,953
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    TMO
    Insiders 0.2%Institutions 94.3%Retail & Other 5.6%
    No. of Institutional Holders3,536
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    ABT
    2
    Buys (3M)
    4
    Buys (12M)
    Total value (12M): $4.23M
    STARKS DANIEL J
    Director
    $926,537
    @ $92.65 · 2026-04-27
    BOUDREAU PHILIP P
    Chief Financial Officer
    $201,300
    @ $91.50 · 2026-04-23
    STARKS DANIEL J
    Director
    $1.09M
    @ $108.73 · 2026-02-04
    FORD ROBERT B.
    Chief Executive Officer
    $2.01M
    @ $107.13 · 2026-01-23
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    TMO
    0
    Buys (3M)
    0
    Buys (12M)
    CHAI NELSON J
    Director
    $11,038
    @ $551.90 · 2024-12-09
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    ABT
    0
    Sells (3M)
    8
    Sells (12M)
    Total value (12M): $1.44M
    SALVADORI DANIEL GESUA SIVE
    Officer
    $102,288
    @ $115.58 · 2026-03-02
    MCCOY JOHN A. JR
    Officer
    $67,614
    @ $115.58 · 2026-03-02
    MORRONE LOUIS H
    Officer
    $132,224
    @ $115.58 · 2026-03-02
    SHROFF ERIC
    Officer
    $81,946
    @ $115.58 · 2026-03-02
    CUSHMAN ELIZABETH C
    General Counsel
    $30,398
    @ $115.58 · 2026-03-02
    MORELAND MARY K
    Officer
    $70,851
    @ $115.58 · 2026-03-02
    SHROFF ERIC
    Officer
    $203,043
    @ $128.02 · 2025-11-25
    BOUDREAU PHILIP P
    Chief Financial Officer
    $746,758
    @ $134.55 · 2025-08-08
    BLOUNT SALLY E
    Director
    $337,116
    @ $129.66 · 2025-04-30
    EARNHARDT LISA D
    President
    $12.23M
    @ $133.83 · 2025-03-07
    MCCOY JOHN A. JR
    Officer
    $77,652
    @ $138.17 · 2025-03-03
    SHROFF ERIC
    Officer
    $77,652
    @ $138.17 · 2025-03-03
    MORELAND MARY K
    Officer
    $109,292
    @ $138.17 · 2025-03-03
    MORRONE LOUIS H
    Officer
    $153,507
    @ $138.17 · 2025-03-03
    WAINER ANDREA F
    Officer
    $131,123
    @ $138.17 · 2025-03-03
    FORD ROBERT B.
    Chief Executive Officer
    $37.44M
    @ $131.17 · 2025-02-05
    SALVADORI DANIEL GESUA SIVE
    Officer
    $3.05M
    @ $128.50 · 2025-01-30
    ALLEN HUBERT L.
    Officer
    $24.34M
    @ $128.26 · 2025-01-30
    ALLEN HUBERT L.
    Officer
    $18.42M
    @ $117.04 · 2024-10-21
    FORD ROBERT B.
    Chief Executive Officer
    $16.49M
    @ $116.41 · 2024-09-12
    MCCOY JOHN A. JR
    Officer
    $3,100
    @ $114.81 · 2024-09-04
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    TMO
    1
    Sells (3M)
    21
    Sells (12M)
    Total value (12M): $110.57M
    PETTITI GIANLUCA
    President
    $185,064
    @ $462.66 · 2026-04-27
    SHAFER MICHAEL D
    Officer
    $802,536
    @ $499.40 · 2026-03-11
    CASPER MARC N
    Chief Executive Officer
    $2.06M
    @ $514.82 · 2026-03-05
    CASPER MARC N
    Chief Executive Officer
    $5.08M
    @ $507.75 · 2026-03-04
    PETTITI GIANLUCA
    Officer
    $216,480
    @ $541.20 · 2026-02-09
    LAGARDE MICHEL
    Chief Operating Officer
    $12.42M
    @ $563.56 · 2025-12-04
    LAGARDE MICHEL
    Chief Operating Officer
    $36.13M
    @ $582.68 · 2025-12-03
    LOWERY FREDERICK M.
    Officer
    $8.15M
    @ $589.81 · 2025-12-02
    SHAFER MICHAEL D
    Officer
    $6.43M
    @ $600.00 · 2025-11-25
    LAGARDE MICHEL
    Chief Operating Officer
    $2.76M
    @ $594.42 · 2025-11-13
    BRITT LISA P
    Officer
    $622,136
    @ $588.59 · 2025-11-12
    PETTITI GIANLUCA
    Officer
    $1.73M
    @ $580.00 · 2025-11-10
    BRITT LISA P
    Officer
    $5.84M
    @ $571.62 · 2025-11-07
    CASPER MARC N
    Chief Executive Officer
    $13.91M
    @ $571.33 · 2025-10-27
    PETTITI GIANLUCA
    Officer
    $229,660
    @ $574.15 · 2025-10-24
    CASPER MARC N
    Chief Executive Officer
    $200,201
    @ $500.50 · 2025-09-05
    HOLMES JOSEPH R.
    Officer
    $189,662
    @ $492.63 · 2025-08-29
    CASPER MARC N
    Chief Executive Officer
    $5.01M
    @ $500.96 · 2025-08-22
    CASPER MARC N
    Chief Executive Officer
    $248,046
    @ $500.09 · 2025-08-20
    CASPER MARC N
    Chief Executive Officer
    $8.15M
    @ $452.99 · 2025-08-07
    PETTITI GIANLUCA
    Officer
    $191,992
    @ $479.98 · 2025-07-25
    PETTITI GIANLUCA
    Officer
    $164,444
    @ $411.11 · 2025-05-12
    PETTITI GIANLUCA
    Officer
    $128,979
    @ $429.93 · 2025-04-28
    BOXER MICHAEL A
    General Counsel
    $2.01M
    @ $532.59 · 2025-03-10
    CASPER MARC N
    Chief Executive Officer
    $9.33M
    @ $518.16 · 2025-03-05
    SHAFER MICHAEL D
    Officer
    $945,038
    @ $530.92 · 2025-03-03
    LOWERY FREDERICK M.
    Officer
    $9.73M
    @ $531.81 · 2025-02-24
    CHAI NELSON J
    Director
    $8,449
    @ $528.06 · 2025-02-19
    WILLIAMSON STEPHEN
    Chief Financial Officer
    $11.58M
    @ $589.36 · 2025-02-04
    PETTITI GIANLUCA
    Officer
    $175,677
    @ $585.59 · 2025-02-04
    CASPER MARC N
    Chief Executive Officer
    $10.62M
    @ $531.23 · 2024-12-03
    CASPER MARC N
    Chief Executive Officer
    $3.26M
    @ $557.89 · 2024-11-01
    CASPER MARC N
    Chief Executive Officer
    $11.01M
    @ $550.51 · 2024-10-31
    CASPER MARC N
    Chief Executive Officer
    $11.05M
    @ $552.46 · 2024-10-29
    PETTITI GIANLUCA
    Officer
    $168,048
    @ $560.16 · 2024-10-25
    BOXER MICHAEL A
    General Counsel
    $1.12M
    @ $560.16 · 2024-10-25
    CASPER MARC N
    Chief Executive Officer
    $12.17M
    @ $608.45 · 2024-09-04
    CASPER MARC N
    Chief Executive Officer
    $6.17M
    @ $617.21 · 2024-07-31
    CASPER MARC N
    Chief Executive Officer
    $9.88M
    @ $606.12 · 2024-07-30
    PETTITI GIANLUCA
    Officer
    $180,255
    @ $600.85 · 2024-07-26
    HOLMES JOSEPH R.
    Officer
    $525,484
    @ $611.03 · 2024-07-26
    BRITT LISA P
    Officer
    $2.22M
    @ $613.02 · 2024-07-26
    BOXER MICHAEL A
    General Counsel
    $1.20M
    @ $600.85 · 2024-07-26
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    ABT
    FearGreed
    😐Neutral(41/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    TMO
    FearGreed
    😨Fear(40/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    ABT
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (41)
    TMO
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (40)
    View ABT Full AnalysisView TMO Full Analysis

    Frequently Asked Questions: ABT vs TMO

    Is Abbott Laboratories or Thermo Fisher Scientific Inc. more undervalued in 2026?

    Based on our discounted cash flow model, ABT trades at a 4.8% margin of safety (intrinsic value $93 vs. price $88), compared to TMO's -14.3% margin of safety (intrinsic $407 vs. $465).

    Which stock has a wider economic moat, Abbott Laboratories or Thermo Fisher Scientific Inc.?

    ABT scores 86/100 (Wide moat), while TMO scores 60/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Which company has better free cash flow, Abbott Laboratories or Thermo Fisher Scientific Inc.?

    Abbott Laboratories (ABT) generates a 4.1% free cash flow yield, compared to Thermo Fisher Scientific Inc.'s 3.2%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, Abbott Laboratories or Thermo Fisher Scientific Inc.?

    TMO earns 6.7% ROIC versus ABT's 5.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, Abbott Laboratories's or Thermo Fisher Scientific Inc.'s?

    TMO's dividend earns a safety score of 94/100 (Very Safe), compared to ABT's 84/100 (Very Safe). TMO has raised its dividend for 3 consecutive years.

    ABT vs TMO: Which Is the Better Buy in 2026? | SafetyMargin.io